がん研究のアーカイブ

  • ISSN: 2254-6081
  • ジャーナル h-index: 13
  • 雑誌引用スコア: 3.58
  • ジャーナルのインパクトファクター: 3.12
インデックス付き
  • 中国国家知識基盤 (CNKI)
  • サイテファクター
  • OCLC-WorldCat
  • パブロン
  • ジュネーブ医学教育研究財団
  • Google スカラー
  • 秘密検索エンジン研究所
このページをシェアする

抽象的な

Brief note on Usage of Biochemicals in Immunotherapy

Wafaey Gomaa, Shiny Nair

For quite a while, wonder of faulty safe observation in malignancy patients from neurotic stance was not clarified. I have detailed 1985 that bringing down cyclic AMP is biochemical explanation of faulty safe observation from receptive lymphocyte immunotherapy explore among malignant growth patients. As of late, why T cell don't assault malignancy cells by the covering of PD-L1 on its receptor of PD-1. This is additionally one of damaged resistant reconnaissance from cell side. I have as of late reviewed the connection between cyclic AMP focus and safe movement in malignancy patients. I have affirmed the biochemical explanation of bringing cyclic AMP drives down to faulty resistant observation in disease patient's serum.